BSECompany Update6d ago · 25 Oct 2026, 08:03 pm
Prior Intimation of the meeting of the Fung Raising Committee of the Board of Director to be held on 29th October, 2026 (Thursday) of the Company for the Rights Issue
Crescentis Capital Ltd · 511571
✦ AI SummaryFundraise
Crescentis Capital Ltd has scheduled a meeting of its Fund-Raising Committee to consider the terms and conditions of a proposed rights issue of up to Rs 80 crores.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment4/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Crescentis Capital Ltd - 511571 - Prior Intimation Of The Meeting Of The Fund-Raising Committee Of The Board Of Directors To Be Held On 29Th October, 2026 (Thursday) Of The Company For Rights Issue.
Attachments (1)
📄pdf
Download →
caa73b04-8501-4b8e-b2fc-dc939105d6a2.pdf
View document text
CRESCENTIS CAPITAL LIMITED
Formerly Known as “Som Datt Finance Corporation Limited”
CIN: L65921TS1993PLC188494
25th October, 2026
Corporate Relations Department
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street
Mumbai – 400001
Scrip Name: Crescentis
(Scrip Code: 511571)
Sub.: Prior Intimation of the meeting of the Fund-Raising Committee of the Board of Directors to be held on 29th
October, 2026 (Thursday)of the Company for Rights Issue.
Dear Sir / Ma’am,
Notice is hereby given that pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, a meeting of the Fund-Raising Committee of the Board of Directors is scheduled to be held on
Thursday, 29th October, 2026, to take on record the letter bearing reference number LOD/RIGHT/
MV/FIP/1005/2026-27 dated 23rd October, 2026 received from BSE Limited granting in-principle approval for
listing of fully paid-up equity shares proposed to be issued on a rights basis, and, inter alia, to consider, discuss
and approve the following business:
1. The terms and conditions related to the proposed issue of Equity Shares on rights basis, including but not
limited to the issue price, payment mechanism, issue size, rights entitlement ratio, record date, and the
timing of the rights issue. This business is in furtherance to our disclosure on the outcome of the meeting
of the Board of Directors of the Company held on September 30, 2026, wherein the Board approved
raising of funds by the issue of equity shares of face value of Rs 10 each of the Company by way of a
rights issue for an amount upto Rs 80 crores (“Rights Issue”) , in accordance with the provisions of the
Companies Act, 2013, as amended and the rules made thereunder; the Securities and Exchange Board
of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended; the Securities
and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and
other applicable laws.
2. Any other matter with the permission of the Chair.
Further, pursuant to the Company's Code of Conduct for Prohibition of Insider Trading, adopted in accordance
with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of
the Company by the Designated Persons and their Immediate Relatives has already been closed with effect from
October 01, 2026, in connection with the consideration and declaration of the Unaudited Financial Results of the
Company for the quarter and half year ending September 30, 2026, as intimated to BSE Limited vide the
Company's letter dated September 23, 2026.
Kindly take the same on record.
Thanking You,
Yours faithfully,
For Crescentis Capital Limited
(Formerly Known as Som Datt Finance Corporation Ltd)
V V Krishna Chaitanya
Company Secretary & Compliance Officer
M.No. A49415
--------------------------------------------------------------------------------------------------------------------------------------
Reg. Office: 8-2-502/1/A, Ground Floor, JIVI Towers, Road No 7, Banjara Hills, Hyderabad - 500034
| Email: cs@crescentis.in | Ph.No: 040-45267248